Gold Severity
Gold Severity - Related Videos
09:31
Gold Nanorod-assisted Optical Stimulation of Neuronal Cells
0 Views •
Cited by 9 •
2015
This protocol outlines how to use the transient heating associated with the optical absorption of gold nanorods to stimulate differentiation and intracellular calcium activity in neuronal cells. These results potentially open up new applications in neural prostheses and fundamental studies in neuroscience.
08:21
Fabrication of Periodic Gold Nanocup Arrays Using Colloidal Lithography
0 Views •
Cited by 1 •
2017
We demonstrate the fabrication of periodic gold nanocup arrays using colloidal lithographic techniques and discuss the importance of nanoplasmonic films.
08:55
Hydroquinone Based Synthesis of Gold Nanorods
0 Views •
Cited by 11 •
2016
This paper describes a protocol for the synthesis of gold nanorods, based on the use of hydroquinone as reducing agent, plus the different mechanisms for controlling their size and aspect ratio.
13:42
Gold Nanoparticle Synthesis
0 Views •
Cited by 2 •
2021
A protocol for synthesizing ~12 nm diameter gold nanoparticles (Au nanoparticles) in an organic solvent is presented. The gold nanoparticles are capped with oleylamine ligands to prevent agglomeration. The gold nanoparticles are soluble in organic solvents such as toluene.
01:23
A Gold Staining Technique to Visualize Myelin Reduction in Stressed Mice
0 Views •
2025
Stress impairs oligodendrocyte function, disrupting the lipid-rich myelin sheath surrounding neuronal axons in the medial prefrontal cortex, a brain region regulating emotion.
FAQs
Post-bronchodilator spirometry provides the lung-function measurement used for GOLD Severity classification after a bronchodilator has been given. The key value is forced expiratory volume in one second, or FEV1, expressed as a percentage of the predicted value. Using this standardized measurement supports consistent interpretation of airflow limitation across patients and clinical settings.
FEV1 percentage predicted places a patient’s measured expiratory performance in relation to an expected reference value. That relationship determines the spirometric severity category, from GOLD 1 through GOLD 4. The result describes airflow limitation, but it should not be treated as a complete summary of symptoms, overall disease burden, or future exacerbation risk.
GOLD Severity reflects airflow limitation measured by spirometry, whereas patients may differ in symptoms, disease burden, and history of exacerbations. Consequently, the same spirometric category can occur alongside different clinical needs. Clinicians combine the GOLD result with patient history and other measures to develop a fuller assessment rather than relying on FEV1 alone.
Assignment begins with spirometry performed after bronchodilator use. Clinicians use the resulting forced expiratory volume in one second and compare it with the predicted value, expressed as a percentage. That percentage is then interpreted within the GOLD 1 to GOLD 4 framework. The classification therefore depends on standardized lung-function data, not symptoms alone.
The classification gives clinicians a structured description of airflow limitation that can contribute to COPD assessment and treatment planning. It does not independently determine every clinical decision, because symptoms and exacerbation risk also matter. Used with those additional measures, the spirometric category helps place lung-function findings within the patient’s broader clinical picture.
A shared GOLD Severity framework gives healthcare professionals a common way to describe the degree of airflow limitation in COPD. Clinicians can use the classification when assessing disease, monitoring lung-function status, and communicating findings with other professionals. Because the category represents spirometric severity rather than the entire disease experience, follow-up interpretation should also consider symptoms and exacerbation history.